The short version
Only one company currently supplies this market — there is no backup if it stumbles.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Arformoterol Tartrate Inhalation Solution
Arformoterol Tartrate Inhalation Solution · ARFORMOTEROL TARTRATE 15 ug/2mL · Solution · Respiratory (Inhalation) · Ritedose Pharmaceuticals, LLC
NDC 76204-0026-01 · 30 POUCH in 1 CARTON / 1 AMPULE in 1 POUCH / 2 mL in 1 AMPULE · ANDA · View full market →
Medicare Part D
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Estimated fill cost
WAC per package, as filed
$75.00
Reported to Texas DSHS · 2026 annual filing · The Ritedose Corporation
Manufacturer list price as filed — not what pharmacies actually pay after discounts.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
90-day shortage risk (model v2)
0.1%chance of a new FDA shortage posting for arformoterol tartrate (other) in the next 90 days
sole-source market
For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.
Backtested statistical model over the whole market, not this package alone. Model details →
Where it's made
- The Ritedose CorporationUnited Statesanalysis · label · manufacture · pack
Establishments this product's FDA label declares, located via FDA registration data. How we built this →
Regulatory
- Application
- ANDA214736
- TE code
- AN
- Approval date
- Mar 2, 2022
- Patents / exclusivity
- None on file
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of Arformoterol Tartrate Inhalation Solution (Solution)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Ritedose Pharmaceuticals, LLC | ARFORMOTEROL TARTRATE 15 ug/2mL | Jul 15, 2026 | Sep 2, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Arformoterol Tartrate Inhalation Solution — NDC 76204-0026-01," retrieved September 3, 2026, https://drugdashboards.com/drug/76204002601.
Free to cite with attribution — see how the data is put together.